Cheryl Scott

CIK: 0001656979

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PGNY

Progyny, Inc.

Director

EVH

Evolent Health, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

PGNY
Progyny, Inc.
Jun 1, 2026
Tax Payment(F)
Direct
7.2K shares at avg. $26.38$191K
PGNY
Progyny, Inc.
Jun 1, 2026
Exercise(M)
Direct
14.7K shares at avg. $13.00$191K
PGNY
Progyny, Inc.
Jun 1, 2026
Sale(S)
Direct
7.4K shares at avg. $26.39$196K
PGNY
Progyny, Inc.
May 21, 2026
Award(A)
Direct
5.7K shares-
PGNY
Progyny, Inc.
Jun 11, 2025
Sale(S)
Direct
2.7K shares at avg. $22.07$59K
EVH
Evolent Health, Inc.
Jun 5, 2025
Award(A)
Direct
22K shares-
PGNY
Progyny, Inc.
May 22, 2025
Award(A)
Direct
6.7K shares-

		Type	Shares	Price		Ownership
Jun 1, 2026	PGNY Progyny, Inc.	Tax Payment(F)	7,228	$26.38	$190,675	Direct
Jun 1, 2026	PGNY Progyny, Inc.	Exercise(M)	14,667	$13.00	$190,671	Direct
Jun 1, 2026	PGNY Progyny, Inc.	Sale(S)	7,439	$26.39	$196,278	Direct
May 21, 2026	PGNY Progyny, Inc.	Award(A)	5,660	-	$0	Direct
Jun 11, 2025	PGNY Progyny, Inc.	Sale(S)	2,675	$22.07	$59,037	Direct
Jun 5, 2025	EVH Evolent Health, Inc.	Award(A)	21,979	-	-	Direct
May 22, 2025	PGNY Progyny, Inc.	Award(A)	6,689	-	-	Direct

1-7 of 7 transactions

About Scott Cheryl

Scott Cheryl (SEC CIK 0001656979) files insider reports with the SEC as Director of Progyny, Inc. (PGNY) and Director of Evolent Health, Inc. (EVH).

Signal8 holds 5 ownership filings by Scott Cheryl, all Form 4s, filed between May 28, 2025 and Jun 3, 2026. Those filings report 7 transactions, from May 22, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Scott Cheryl's filings is in NEW YORK, NY.

Recent filings by Scott Cheryl

Jun 1, 2026: Tax withholding of PGNY shares (Form 4, code F).
Jun 1, 2026: Option exercise of PGNY shares (Form 4, code M).
Jun 1, 2026: Open-market sale of PGNY shares (Form 4, code S).
May 21, 2026: Grant or award of PGNY shares (Form 4, code A).
Jun 11, 2025: Open-market sale of PGNY shares (Form 4, code S).

Other insiders filing for Progyny, Inc. (PGNY)

Cummings Melissa B, Chief Operating Officer
Swartz Allison, EVP, GC
Clapp Geoffrey, Chief Product Officer
GORDON KEVIN K, Director
Anevski Peter, CHIEF EXECUTIVE OFFICER
Livingston Mark S., CHIEF FINANCIAL OFFICER

How to read Form 4 transaction codes